The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00280-010-1287-zPMID 20306194PMCID PMC2916050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of chemotherapy response in osteosarcoma with FDG-PET

  2009influential reference
• Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell death

  2009cited by this paper
• The Multidisciplinary Management of Osteosarcoma

  2009cited by this paper
• Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

  2008cited by this paper
• High Histone Deacetylase 7 (HDAC7) Expression Is Significantly Associated with Adenocarcinomas of the Pancreas

  2008cited by this paper
• Novel targets with potential therapeutic applications in osteosarcoma

  2008cited by this paper
• Transforming pathways unleashed by a HDAC2 mutation in human cancer

  2008cited by this paper
• Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

  2008cited by this paper
• Combination therapy with valproic acid in cancer: Initial clinical approach

  2007cited by this paper
• Faithful companions: a proposal for neurooncology trials in pet dogs.

  2007cited by this paper
• Comparative biology of human and canine osteosarcoma.

  2007cited by this paper
• Valproic acid, a molecular lead to multiple regulatory pathways.

  2007cited by this paper
• Addition of histone deacetylase inhibitors in combination therapy.

  2007cited by this paper
• Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study.

  2007cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma.

  2006cited by this paper
• Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.

  2006cited by this paper
• Phase I trial of the histone deacetylase inhibitor, valproic acid and the topoisomerase II inhibitor, epirubicin: A clinical and translational Study

  2005cited by this paper
• In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates

  2005cited by this paper
• Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP

  2005cited by this paper
• Valproic acid alters chromatin structure by regulation of chromatin modulation proteins.

  2005cited by this paper
• Histone deacetylation in epigenetics: An attractive target for anticancer therapy

  2005cited by this paper
• Sequence‐specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

  2004cited by this paper
• Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.

  2004cited by this paper
• Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells

  2004cited by this paper
• The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

  2004cited by this paper
• Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.

  2004cited by this paper
• Spontaneously Occurring Tumors in Companion Animals as Models for Drug Development

  2004cited by this paper
• Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.

  2003cited by this paper
• FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells

  2003cited by this paper
• The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.

  2003cited by this paper
• MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.

  2002cited by this paper
• Histone deacetylases and cancer: causes and therapies

  2001cited by this paper
• Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma.

  1995cited by this paper
• Efficacy of Liposomal Muramyl Tripeptide (CGP 19835A) in the Treatment of Relapsed Osteosarcoma

  1995cited by this paper
• Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide.

  1989cited by this paper

• Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids

  2025cites this paper
• Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma

  2025cites this paper
• Epigenetic remodeling under oxidative stress: Mechanisms driving tumor metastasis

  2024cites this paper
• Histone epigenetic modifications and their relationship with cancer: a comparative medicine view

  2023cites this paper
• Epigenetics and precision medicine in bone and soft tissue sarcomas

  2022cites this paper
• Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

  2022cites this paper
• University of Birmingham Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells

  2021cites this paper
• The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma

  2021cites this paper
• Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma

  2020cites this paper
• Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells

  2020cites this paper
• HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU

  2020cites this paper
• Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer

  2020cites this paper
• The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma.

  2020cites this paper
• miR-143 promotes angiogenesis and osteoblast differentiation by targeting HDAC7

  2020cites this paper
• Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma.

  2020cites this paper
• Epigenetic Mechanisms in Canine Cancer

  2020cites this paper
• Molecular/Targeted Therapy of Cancer

  2019cites this paper
• HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells

  2019cites this paper
• Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations.

  2019cites this paper
• Salinomycin decreases feline sarcoma and carcinoma cell viability when combined with doxorubicin

  2019cites this paper
• Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach

  2018cites this paper
• Positive effects of antitumor drugs in combination with propolis on canine osteosarcoma cells (spOS-2) and mesenchymal stem cells.

  2018cites this paper
• Leveraging Epigenetics to Enhance the Cellular Response to Chemotherapies and Improve Tumor Immunogenicity

  2018cites this paper
• SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy

  2018cites this paper
• Epigenetics and Orthopedics

  2017cites this paper
• Targeted inhibition of HDAC8 increases the doxorubicin sensitivity of neuroblastoma cells via up regulation of miR‐137

  2017cites this paper
• Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells.

  2017cites this paper
• Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis

  2017cites this paper
• Valproic Acid as a Promising Co-Treatment With Paclitaxel and Doxorubicin in Different Ovarian Carcinoma Cell Lines

  2016cites this paper
• Screening and improving the safe provision of mesenchymal stem cells in regenerative medicine : an in vitro study

  2016cites this paper
• Pharmacological Modulation of Photoreceptor Outer Segment Degradation in a Human iPS Cell Model of Inherited Macular Degeneration.

  2015cites this paper
• Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

  2015cites this paper
• Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival

  2015influential citation
• Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma

  2015cites this paper
• Histone deacetylase inhibitors repress chondrosarcoma cell proliferation.

  2015cites this paper
• CANINE OSTEOSARCOMA: A RELEVANT COMPARATIVE MODEL FOR OSTEOSARCOMA IN MAN

  2015cites this paper
• A polysaccharide from Trametes robiniophila Murrill induces apoptosis through intrinsic mitochondrial pathway in human osteosarcoma (U-2 OS) cells

  2015cites this paper
• Histone Deacetylases in Bone Development and Skeletal Disorders.

  2015cites this paper
• Inhibition of focal adhesion kinase induces apoptosis in human osteosarcoma SAOS-2 cells

  2014cites this paper
• Epigenetic alterations in osteosarcoma: promising targets

  2014cites this paper
• Antitumour effect of valproic acid against salivary gland cancer in vitro and in vivo.

  2014cites this paper
• Small molecule inhibitors in veterinary oncology practice.

  2014cites this paper
• Depression of Focal Adhesion Kinase Induces Apoptosis in Rat Osteosarcoma OSR-6 Cells in a Caspase-Dependent Pathway

  2014cites this paper
• Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway

  2014cites this paper
• A NANOPARTICLE-BASED EPIGENETIC MODULATOR FOR EFFICIENT GENE MODULATION

  2014cites this paper
• Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells

  2013cites this paper
• Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.

  2013cites this paper
• Matrine inhibited the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis in a mitochondrial–caspase-dependent pathway

  2013cites this paper
• Role of Epigenetic Modulation for the Treatment of Sarcoma

  2013cites this paper
• Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.

  2013cites this paper
• Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.

  2013cites this paper
• Cultured Cells by Valproic Acid Inhibition of Enveloped Virus Infection of

  2013cites this paper
• A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.

  2012cites this paper
• Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2

  2012cites this paper
• A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma

  2012cites this paper
• Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Whether Nanomolar Potency Should Be Required of Candidate Agents

  2012cites this paper
• Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.

  2012cites this paper
• The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment.

  2012cites this paper
• Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines

  2012cites this paper
• Bone Sarcomas: From Biology to Targeted Therapies

  2012cites this paper
• The histone deacetylase inhibitor vorinostat selectively sensitizes fibrosarcoma cells to chemotherapy

  2011cites this paper
• Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment.

  2011cites this paper
• Epigenetic changes in osteosarcoma.

  2011cites this paper
• Valproic acid synergistically enhances the cytotoxicity of gossypol in DU145 prostate cancer cells: an iTRTAQ-based quantitative proteomic analysis.

  2011cites this paper
• Canine osteosarcoma: a relevant comparative model for osteosarcoma in man

  2011cites this paper
• Phase I Pharmacokinetic and Pharmacodynamic Evaluation of Combined Valproic Acid/Doxorubicin Treatment in Dogs with Spontaneous Cancer

  2010cites this paper
• Spontaneous Cancer

  2010cites this paper
• Inhibition of Enveloped Virus Infection of Cultured Cells by Valproic Acid

  2010cites this paper
• Cancer esearch cer Therapy : Preclinical se I Pharmacokinetic and Pharmacodynamic Evaluation ombined Valproic Acid / Doxorubicin Treatment in Dogs R Spontaneous Cancer

  2010cites this paper
• Interaction of daunomycin with acetylated chromatin.

  2010cites this paper
• How can survival be improved in localized osteosarcoma?

  2010cites this paper
• Optimization of a fluorimetric assay for the search for histone deacetylase modulators from plant origin and its application in bioactivity-guided isolation

  2010cites this paper